GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
6.00
+0.02 (0.33%)
At close: Dec 5, 2025, 4:00 PM EST
5.96
-0.04 (-0.67%)
After-hours: Dec 5, 2025, 6:51 PM EST
GlucoTrack Market Cap
GlucoTrack has a market cap or net worth of $5.46 million as of December 5, 2025. Its market cap has increased by 97.66% in one year.
Market Cap
5.46M
Enterprise Value
893.13K
1-Year Change
97.66%
Ranking
Category
Stock Price
$6.00
Market Cap Chart
Since April 25, 2013, GlucoTrack's market cap has decreased from $34.13M to $5.46M, a decrease of -83.99%. That is a compound annual growth rate of -13.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 5.46M | -8.73% |
| Dec 31, 2024 | 5.99M | 9.59% |
| Dec 29, 2023 | 5.46M | -74.96% |
| Dec 30, 2022 | 21.82M | -66.12% |
| Dec 31, 2021 | 64.40M | -9.57% |
| Dec 31, 2020 | 71.22M | -26.72% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |